NEW YORK (GenomeWeb News) – Thermo Fisher Scientific recorded about $55.6 million in restructuring charges related to the termination of employees during 2013, the company said in its Form 10-K on Thursday.

The company took charges in its Analytical Technologies segment of $18.5 million; in its Specialty Diagnostics segment of $17.8 million; in its Laboratory and Products Services segment of $16.3 million; and in corporate of $3.0 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.